SCHEMBL4531386

SCHEMBL4531386

CC(=O)N1CCN(C(=O)c2[nH]c3ccccc3c2CN2CCC(c3c(C)cccc3C)CC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
MCL1 Q07820 5/20 0.44
POLB P06746 2/20 0.42
BRD4 O60885 1/20 0.42
CREBBP Q92793 1/20 0.42
HTR2A P28223 1/20 0.41
DRD2 P14416 2/20 0.40
DRD3 P35462 2/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4529531 0.92 KDM4E (0.45) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL4510224 0.92 KDM4E (0.46) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL4528287 0.92 KDM4E (0.46) KDM4EALDH1A1MEN1KMT2AMAPT
Trifluoroacetic Acid SCHEMBL4515642 0.92 KDM4E (0.43) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL4519514 0.91 KDM4E (0.46) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL4530667 0.91 KDM4E (0.46) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL4525427 0.91 HTR2A (0.51) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL4505975 0.90 KDM4E (0.45) KDM4EALDH1A1MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL4519164 0.90 KDM4E (0.45) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL4505463 0.90 MAPT (0.45) KDM4EALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor BRANE DISCOVERY S.R.L. (IT) 2009-11-05 US claimed
EP-1841755-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2007-10-10 EP claimed
WO-2006070001-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2006-07-06 WO claimed
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor BRANE DISCOVERY S.R.L. (IT) 2009-11-05 US disclosed
EP-1841755-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2007-10-10 EP disclosed
WO-2006070001-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2006-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor OGFRL1, OPRL1, ORMDL3 KDM4E 4525/4885ALDH1A1 395/4885MEN1 2146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.